ABSTRACT
Yöntemler: Hastalar Osteogenezis imperfekta (OI) tiplerine göre gruplandırıldı. Yaş ve cinsiyetleri not edildi. Refraksiyon, göz içi basıncı (GİB) santral korneal kalınlık (SKK) değerleri ölçüldü. Korneal topografi görüntüleri alındı. Tüm hastaların fundus muayeneleri yapıldı. Sferik eşdeğerleri ve en iyi düzeltilmiş görme keskinlikleri (EDGK) kaydedildi. Hastalarda skleral renk değişikliği olup olmadığı not edildi.

Bulgular: Bu çalışmada, 15 hastanın 30 gözü incelenmiştir. On beş hastanın 8'i Tip 1 OI, 5'i Tip 4 OI ve 2'si de
The most frequent ophthalmic finding is blue sclera. Blue sclera is seen in OI Type 1 patients but doesn't occur in OI Type 4 patients. There is a weak correlation between blue sclera and other findings of the disease 6 . Another important and common ocular finding in this disease is thinning in the central corneal thickness (CCT) 1, 7, 8 . Other ocular findings include decreased ocular rigidity, myopia, glaucoma, keratoconus, corneal opacities, small corneal radius, congenital Bowman's layer agenesis, and posterior embryotoxon 1, 9 . Congenital glaucoma, zonular cataract, choroidal sclerosis, subhyaloid hemorrhage, ectopia lentis, optic neuropathy, or atrophy because of compression deformities and cranial fractures are other ophthalmologic disorders that rarely occur with OI 9 .
In this study, our aim was to research ocular findings in children with OI at our hospital's pediatric clinic.
mATerIAl and meThods
Thirty eyes of 15 patients were included in this study.
Local ethics committee approval was obtained for the study. The ethical principles of Helsinki declaration were followed during the study. All patients were examined by the same physician in the same room and at the same time of the day. Patients with history of dry eye and corneal injury, patients who used topical eye drops or contact lenses, and patients who were examined with gonioscopy were excluded from the study. Patients were divided into groups by Sillence classification. Ages and genders of the patients were noted. Firstly, 1% tropicamide and 1% cyclopentolate hydrochloride were both instilled once at 5 minute-intervals aparts, and after 30 minutes, refractive values were measured with a Canon RK-F1 autorefractometer (Canon, Tokyo, Japan). The best corrected visual acuity (BCVA) was obtained with a Snellen chart according to refractive values. Corneal apex, posterior elevation, corneal astigmatism values, and CCT were measured 3 times with Sirius topography (Costruzione Strumenti Oftalmici, Florence, Italy), and mean values were recorded. Intraocular pressure (IOP) was measured with a Topcon CT 80 non-contact tonometer (Topcon, Tokyo, Japan), and the corrected IOP levels were calculated by the CCT. Fundus examinations were made with a 90D lens at biomicroscopy.
Descriptive statistics such as mean along with standard deviation, minimum, maximum values and median were reported for the data. Kolmogorov-Smirnov test was used to test normality of the distributions. Mann-Whitney test was used to compare groups for quantitative variables, and for nominal variables we used chi-square test. Hypothesis test results with p<0.05 was considered to be statistically significant. SPSS 22.0 (SPSS, Inc., Chicago, Illinois) was used for statistical analysis.
resulTs
A total of 30 eyes from 15 patients were included in the study. Of these 15 patients, 8 had OI Type 1, 5 had OI Type 4, and 2 couldn't be classified by Sillence's classification. One of that patients had an FKBP10 mutation, and another one a WNT1 mutation. Mean age of the patients was 15.3±5.4 years. Mean val-ues for spherical equivalent (SE) (-0.5±1.2 D), BCVA (0.8±0.2), IOP (16.1±2.6 mmHg) were as indicated. The lowest CCT value was 397 μm, and the highest value was 588 μm. Mean CCT was 492±67.49 μm. For 16 eyes of 8 patients, the CCT values were under 500 μm. Of these patients, 6 had CCT values under 450 μm and 1 had a CCT value under 400 μm. Blue sclera was discovered in 8 eyes of 4 patients (26.7%). All of these patients were classified as OI Type 1. Also, 50% of all of the OI Type 1 patients had blue sclera. Characteristics of the patients are shown in Table 1 . Table 2 ). In our topography measurements, there was no significant difference between groups in terms of posterior elevation (p=0.417) but there was a statistically significant difference in terms of corneal apex keratometry (K) and corneal astigmatism values (p<0.01, p<0.05, respec- Table 3 ). Corneal apex K and corneal astigmatism values were higher in the OI Type 4 group than the Type 1 group.
There was no significant difference in terms of posterior elevation values and corneal astigmatism values between patients with and without blue sclera (p=0.141, p=0.674, respectively). Contrary to expectations, this meant that CCT was higher in the patients with blue sclera than the patients without blue sclera (508.2±71.9 µm vs. 449.3±21.1 µm), but the difference was not significant (p=0.318). However, the corneal apex K value was significantly different between these two groups (p<0.05; Table 4 ).
Funduscopic examination revealed bone spicules in both eyes of a patient. Also, FKBP mutation was present, and altered electroretinogram values were compatible with retinitis pigmentosa. There was no significant retinal pathology in the fundoscopies of other patients.
DISCuSSION
The cornea and sclera consist of collagen. Therefore, it is expected to see corneal and scleral abnormalities in OI. In their study, Heabra et al. found immature collagen structures in patients with OI (10) . In research on postmortem tissues from 4 OI Type 4 patients by Chan et al. and research on OI Type 3 patients by Miatz et al., it was indicated that there was a 25% decrease in collagen fiber diameters, 50% decrease in scleral fibers, and a decrease in collagen cross linings. These authors also stated that scleral collagen alignment becomes more uniform and scleral light transmission increases, causing underlying uveal tissue to become visible, which is the reason why sclera appears to be blue in OI patients 11, 12 .
In the present study, there were 8 eyes with blue sclera. All of these patients were in the OI Type 1 group, and 50% of OI Type 1 patients had blue sclera. In our opinion, evaluation of blue sclera in OI patients is a subjective method, and this leads to inconsistencies in literature data. Evereklioğlu et al. compared CCT of 12 OI Type 1 patients with blue sclera and 11 OI Type 4 patients without blue sclera with a healthy control group by using ultrasonic pachymetry. They found that in 95.6% of patients, CCT thickness was under 500 μm, and in 65.2% of patients, CCT thickness was under 450 μm. Also, when they compared these findings with the control group, they found statistically significant thinning in OI patients. Mean CCT in the Type 1 patients with blue sclera (446.5±16.3 µm) was thinner than in the Type 4 patients without blue sclera (473.6±25 μm), and this difference was statistically significant 1 
.
In the present study, CCT was under 500 μm in 16 eyes out of 30 (53%). Mean CCT was 461±44 μm in the Type 1 group and 508±79 μm in Type 4 group. Mean CCT was thinner in the Type 1 group, but this difference wasn't statistically significant. Evereklioğlu et al. found no significant difference in the terms of IOP between Type 1 and Type 4 patients. However, mean IOP of OI patients (12.7±1.8 mmHg) was lower than mean IOP of the control group (15.6±1.9 mmHg), and this difference was statistically significant 1 . In the present study, Evereklioğlu et al. compared the SE of eyes in Type 1, Type 4, and control groups and found no significant differences between them. Also, the mean refractive error was -0.32±0.5 D, and visual acuity was between the 20/40 and 20/20 range in 91.3% of the patients. In our study, mean spherical equivalence was -0.5±1.2 D, and mean BCVA was 0.8±0.2. There was no statistically significant difference between Type 1 and Type 4 patients in term of mean spherical equivalence but BCVA was significantly higher in the OI Type 1 group than the OI Type 4 group.
In Type 4 patients, the corneal apex K value was 47.99 D and corneal astigmatism was 2.0 D. These were statistically significantly higher than in OI Type 1 patients. Lower BCVA values in the Type 4 patients could be related to this difference. However, there was no statistically significant difference in terms of CCT and posterior elevation.
In this study, CCT, corneal apex K value, corneal astigmatism, and posterior elevation values were lower in the patients with blue sclera than the patients without blue sclera, but only the difference in the corneal apex K value was statistically significant. When we evaluated all of the topographical findings, we could not reach a clear conclusion about the difference between groups regarding the risk of development up keratoconus. The low number of patients in our study was a limiting factor, so studies with higher sample sizes are needed to evaluate the relationship between corneal ectasia and blue sclera.
ConClusIon
In addition to blue sclera, plenty of ophthalmological findings can be seen in OI patients. One of the most important finding in OI is thinning in the CCT. Therefore, ophthalmologists should be cautious about underestimation of the IOP. CCT must be considered in OI patients who are candidates for refractive surgery. Patients should be warned about the use of protective glasses to prevent ocular traumas because eye rupture can occur more easily than in healthy patients and cause serious morbidities. Our findings in patients with OI were steep K values especially in Type 4 group.So patients should be followed up regularly for keratoconus.
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